Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 28 August at 4:30pm because of system upgrades. We expect to open them again on Friday 29 August at 8am the latest.

To main content To sitemap To news Check availability details

Development of a Novel First-in-Class Biologic Succinate Modulation Therapy for Crohn’s Disease

Reference number
Coordinator IVRS AB
Funding from Vinnova SEK 4 195 835
Project duration November 2025 - November 2027
Status Ongoing
Venture Eurostars

Last updated 26 August 2025

Reference number 2025-01786